https://orcid.org/0000-0003-0026-2839
References
- Sayani FA, Lanzkron S. Hemolytic Anemias. American Society of Hematology Self-Assessment Program, 6th ed. Washington (DC, USA): American Society of Hematology. 2016:139–147.
- Keohane E, Smith L, Walenga J, et al. Thalassemias. Rodak’s Hematology Clinical Principles and Applications, 5th ed. St. Louis (MO, USA): Elsevier. 2016:458–466.
- Lorey F, Charoenkwan P, Witkowsa HE, et al. Hb H hydrops foetalis syndrome: a case report and review of literature. Br J Haematol. 2001;115(1):72–78.
- Gomes S, Picanço I, Miranda A, et al. Hb Évora [alpha2-35 (B16), Ser→Pro], a novel hemoglobin variant associated with an alpha-thalassemia phenotype. Haematologica. 2007;92(2):252–253.
- Waye JS, Chui DHK. Hb Évora [alpha 2-35, Ser->Pro], a novel hemoglobin variant associated with an alpha-thalassemia phenotype. Haematologica. 2007;92(5):e68.
- Liu YT, Old JM, Miles K, et al. Rapid detection of alpha thalassaemia deletions and alpha globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108(2):295–299.
- Bain BJ. The α, β, δ and γ thalassemias and related conditions. Hemoglobinopathy Diagnosis, 3rd ed. Hoboken (NJ, USA): Wiley Blackwell, 2020:85–184.